Ask AI

Congress to Clinic: Expert Perspectives on Therapeutic Advances and Practice-Changing Data Emerging from the 2025 EHA and ICML Congresses *

Gain expert insights on emerging data for novel and potentially practice-changing agents recently discussed at the 2025 EHA and ICML congresses to expand treatment options and enhance outcomes for patients with hematologic malignancies through an educational podcast, expert-authored ClinicalThought commentary, and certified text module with accompanying downloadable slideset.

Share

Program Content

Activities

NHL ALL From EHA ICML 2025
Key Advances in Lymphomas and Acute Lymphocytic Leukemia From EHA and ICML 2025
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: July 28, 2025

Expires: January 27, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.